andecaliximab
Showing 1 - 9 of 9
Gastric Adenocarcinoma Trial in Nagoya, Osaka, Tokyo (Andecaliximab, S-1, Cisplatin)
Terminated
- Gastric Adenocarcinoma
- Andecaliximab
- +4 more
-
Nagoya, Japan
- +2 more
Nov 30, 2020
Ulcerative Colitis Trial in Worldwide (Andecaliximab, Placebo to match Andecaliximab)
Completed
- Ulcerative Colitis
- Andecaliximab
- Placebo to match Andecaliximab
-
Monroe, Louisiana
- +15 more
Jan 5, 2021
COPD Trial in United States (Andecaliximab, Placebo to match Andecaliximab)
Completed
- Chronic Obstructive Pulmonary Disease
- Andecaliximab
- Placebo to match Andecaliximab
-
Miami, Florida
- +4 more
Aug 21, 2020
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Andecaliximab, Nivolumab)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Andecaliximab
- Nivolumab
-
Los Angeles, California
- +33 more
Sep 17, 2020
Pancreatic Cancer, NSCLC, Esophagogastric Cancer Trial in United States (Andecaliximab, Gemcitabine, Nab-paclitaxel)
Completed
- Pancreatic Cancer
- +4 more
- Andecaliximab
- +10 more
-
Birmingham, Alabama
- +17 more
May 20, 2020
Gastric Adenocarcinoma Trial in Worldwide (Andecaliximab, Placebo, Leucovorin)
Completed
- Gastric Adenocarcinoma
- Andecaliximab
- +4 more
-
La Jolla, California
- +133 more
May 11, 2020
Cystic Fibrosis Trial in Worldwide (Andecaliximab, Placebo)
Terminated
- Cystic Fibrosis
- Andecaliximab
- Placebo
-
New Lambton, New South Wales, Australia
- +4 more
Jul 20, 2018
Rheumatoid Arthritis Trial in United States (Andecaliximab, Placebo, Methotrexate)
Terminated
- Rheumatoid Arthritis
- Andecaliximab
- +3 more
-
Palo Alto, California
- +7 more
May 31, 2018